Trinity Biotech PLC
NASDAQ:TRIB

Watchlist Manager
Trinity Biotech PLC Logo
Trinity Biotech PLC
NASDAQ:TRIB
Watchlist
Price: 1.67 USD -3.47% Market Closed
Market Cap: 15.8m USD
Have any thoughts about
Trinity Biotech PLC?
Write Note

Intrinsic Value

The intrinsic value of one TRIB stock under the Base Case scenario is 7.25 USD. Compared to the current market price of 1.67 USD, Trinity Biotech PLC is Undervalued by 77%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TRIB Intrinsic Value
7.25 USD
Undervaluation 77%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Trinity Biotech PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for TRIB cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about TRIB?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Health Care Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Trinity Biotech PLC

Provide an overview of the primary business activities
of Trinity Biotech PLC.

What unique competitive advantages
does Trinity Biotech PLC hold over its rivals?

What risks and challenges
does Trinity Biotech PLC face in the near future?

Summarize the latest earnings call
of Trinity Biotech PLC.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Trinity Biotech PLC.

Provide P/S
for Trinity Biotech PLC.

Provide P/E
for Trinity Biotech PLC.

Provide P/OCF
for Trinity Biotech PLC.

Provide P/FCFE
for Trinity Biotech PLC.

Provide P/B
for Trinity Biotech PLC.

Provide EV/S
for Trinity Biotech PLC.

Provide EV/GP
for Trinity Biotech PLC.

Provide EV/EBITDA
for Trinity Biotech PLC.

Provide EV/EBIT
for Trinity Biotech PLC.

Provide EV/OCF
for Trinity Biotech PLC.

Provide EV/FCFF
for Trinity Biotech PLC.

Provide EV/IC
for Trinity Biotech PLC.

Show me price targets
for Trinity Biotech PLC made by professional analysts.

What are the Revenue projections
for Trinity Biotech PLC?

How accurate were the past Revenue estimates
for Trinity Biotech PLC?

What are the Net Income projections
for Trinity Biotech PLC?

How accurate were the past Net Income estimates
for Trinity Biotech PLC?

What are the EPS projections
for Trinity Biotech PLC?

How accurate were the past EPS estimates
for Trinity Biotech PLC?

What are the EBIT projections
for Trinity Biotech PLC?

How accurate were the past EBIT estimates
for Trinity Biotech PLC?

Compare the revenue forecasts
for Trinity Biotech PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Trinity Biotech PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Trinity Biotech PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Trinity Biotech PLC compared to its peers.

Compare the P/E ratios
of Trinity Biotech PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing Trinity Biotech PLC with its peers.

Analyze the financial leverage
of Trinity Biotech PLC compared to its main competitors.

Show all profitability ratios
for Trinity Biotech PLC.

Provide ROE
for Trinity Biotech PLC.

Provide ROA
for Trinity Biotech PLC.

Provide ROIC
for Trinity Biotech PLC.

Provide ROCE
for Trinity Biotech PLC.

Provide Gross Margin
for Trinity Biotech PLC.

Provide Operating Margin
for Trinity Biotech PLC.

Provide Net Margin
for Trinity Biotech PLC.

Provide FCF Margin
for Trinity Biotech PLC.

Show all solvency ratios
for Trinity Biotech PLC.

Provide D/E Ratio
for Trinity Biotech PLC.

Provide D/A Ratio
for Trinity Biotech PLC.

Provide Interest Coverage Ratio
for Trinity Biotech PLC.

Provide Altman Z-Score Ratio
for Trinity Biotech PLC.

Provide Quick Ratio
for Trinity Biotech PLC.

Provide Current Ratio
for Trinity Biotech PLC.

Provide Cash Ratio
for Trinity Biotech PLC.

What is the historical Revenue growth
over the last 5 years for Trinity Biotech PLC?

What is the historical Net Income growth
over the last 5 years for Trinity Biotech PLC?

What is the current Free Cash Flow
of Trinity Biotech PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for Trinity Biotech PLC.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Trinity Biotech PLC

Current Assets 46m
Cash & Short-Term Investments 5.3m
Receivables 17.7m
Other Current Assets 23m
Non-Current Assets 48.4m
PP&E 3.9m
Intangibles 41.8m
Other Non-Current Assets 2.7m
Current Liabilities 25.8m
Accounts Payable 23.1m
Other Current Liabilities 2.7m
Non-Current Liabilities 98m
Long-Term Debt 91m
Other Non-Current Liabilities 7m
Efficiency

Earnings Waterfall
Trinity Biotech PLC

Revenue
58.7m USD
Cost of Revenue
-38.5m USD
Gross Profit
20.1m USD
Operating Expenses
-34.7m USD
Operating Income
-14.6m USD
Other Expenses
-7.7m USD
Net Income
-22.3m USD

Free Cash Flow Analysis
Trinity Biotech PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Trinity Biotech experienced a significant quarter with revenues reaching $15.8 million, up 14% year-over-year. Point-of-care sales more than doubled, driven by the successful scaling of TrinScreen HIV, which generated $3.1 million, aligning with projections for $8 million in 2024. An impressive 50% quarter-on-quarter growth and a 45% increase in operating profitability underpinned ongoing efficiencies. The company anticipates annualized revenues of approximately $75 million and EBITDASO of $20 million by Q2 2025. Additionally, progress in their continuous glucose monitoring technologies promises future growth, with clinical trials slated for completion within the next year.

What is Earnings Call?
Fundamental Scores

TRIB Profitability Score
Profitability Due Diligence

Trinity Biotech PLC's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional ROE
Positive Gross Profit
ROE is Increasing
40/100
Profitability
Score

Trinity Biotech PLC's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

TRIB Solvency Score
Solvency Due Diligence

Trinity Biotech PLC's solvency score is 29/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Positive Net Debt
29/100
Solvency
Score

Trinity Biotech PLC's solvency score is 29/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TRIB Price Targets Summary
Trinity Biotech PLC

There are no price targets for TRIB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for TRIB?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for TRIB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Trinity Biotech PLC Logo
Trinity Biotech PLC

Country

Ireland

Industry

Health Care

Market Cap

15.8m USD

Dividend Yield

0%

Description

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. The company is headquartered in Bray, Wicklow. The firm's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. The company operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business.

Contact

WICKLOW
BRAY
Ida Business Park, Bray, Co Wicklow, Ireland
+1135312955111.0
www.trinitybiotech.com

IPO

1992-10-21

Employees

543

Officers

President, CEO, Company Secretary & Director
Mr. John Gillard
Founder, Director & Executive Advisor
Mr. Ronan O'Caoimh
Executive Director of Business Development & Executive Director
Dr. James Walsh Ph.D.
CFO & Chief Accounting Officer
Ms. Louise Tallon
Director of Operations
Ms. Jacqueline O'Neill
Chief Technology Officer
Dr. Gary Keating Ph.D.
Show More
Chief Information Officer
Ms. Eibhlin Kelly
Group Director of Human Resources & Culture
Mr. Colm Molloy
Chief Commercial Officer
Mr. Adrian Donohue
Show Less

See Also

Discover More
What is the Intrinsic Value of one TRIB stock?

The intrinsic value of one TRIB stock under the Base Case scenario is 7.25 USD.

Is TRIB stock undervalued or overvalued?

Compared to the current market price of 1.67 USD, Trinity Biotech PLC is Undervalued by 77%.

Back to Top